// AST – IMS - [DMinute_ROS]

Finance News

Goldman Sachs Group Upgrades Puma Biotechnology (PBYI) to Neutral

Goldman Sachs Group Upgrades Puma Biotechnology (PBYI) to Neutral

Puma Biotechnology (NASDAQ:PBYI) was upgraded by equities research analysts at Goldman Sachs Group from a “sell” rating to a “neutral” rating in a research report issued to clients and investors on Monday, The Fly reports.

Alexion Pharmaceuticals, Inc. (ALXN) Holdings Trimmed by Granite Investment Partners LLC

Alexion Pharmaceuticals, Inc. (ALXN) Holdings Trimmed by Granite Investment Partners LLC

Granite Investment Partners LLC trimmed its holdings in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) by 6.2% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 44,369 shares of the biopharmaceutical company’s stock after selling 2,917 shares during the quarter. Granite Investment […]